NFU1
protein-codingNFU1 iron-sulfur cluster scaffold, the group of Mitochondrial iron-sulfur assembly components
Gene summary
This gene encodes a protein that is localized to mitochondria and plays a critical role in iron-sulfur cluster biogenesis. The encoded protein assembles and transfers 4Fe-4S clusters to target apoproteins including succinate dehydrogenase and lipoic acid synthase. Mutations in this gene are a cause of multiple mitochondrial dysfunctions syndrome-1, and pseudogenes of this gene are located on the short arms of chromosomes 1 and 3. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
- HIRIP5
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~41.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011582
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0011582
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011582
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011582
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *NFU1* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of July 11, 2023. *NFU1* encodes a protein essential to the assembly of iron-sulfur (Fe-S) clusters. *NFU1* was first reported in relation to autosomal recessive primary mitochondrial disease in 2011 (PMID:21944046, although this case was first reported in 2001, PMID:11156534), in an infant who died at age one month due to respiratory failure in the setting of metabolic acidosis, hyperglycinemia and multiple organ failure. Tissue testing indicated a clear reduction in lipoate containing 2-oxoacid dehydrogenases (pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase) as well as defects in complexes I, II, and III which is characteristic of this Fe-S cluster defect. While various names have been given to the constellation of features seen in those with *NFU1*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *NFU1* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included six unique variants (two frameshift null variants, three missense variants, and one predicted missense variant resulting in aberrant splicing) in five probands from three publications (PMIDs: 22077971, 25918518, 25758857), although many additional cases (~35) are reported in the medical literature. The p.Gly208Cys variant appears to be a Basque founder variant. Affected individuals have a strikingly similar biochemical phenotype but variable severity of their clinical phenotype. Two general clinical phenotypes have been reported. One is an infantile onset, potentially fatal, lactic acidosis with leukoencephalopathy with or without pulmonary hypertension, optic atrophy, and/or cardiomyopathy. The second is an early childhood onset hereditary spastic paraplegia with leukoencephalopathy and regression. Affected individuals show a reduction in activities and amounts of lipoate containing enzymes as well as hyperglycinemia/hyperglycinuria (PMIDs: 22077971, 25918518, 25758857). This gene-disease association is also supported by functional implication given protein interaction with other genes involved in Fe-S cluster assembly or lipoylation (PMID: 33007329). HeLa cell models and yeast cell models replicating similar biochemical defects seen in patients (PMID: 22077971) and functional deficiencies seen in patient cells (PMID:36256512) were also included in scoring. In summary, there is definitive evidence to support the relationship between *NFU1* and primary mitochondrial disease. This has been repeatedly demonstrated and upheld over time, and no convincing evidence has emerged that contradicts this gene-disease relationship. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on July 11, 2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0011582
Submitter: Genomics England PanelApp
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NFU1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001002755.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 27 | 1 | 31 | ||
| missense | 7 | 4 | 62 | 3 | 76 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 2 | 1 | 4 | ||
| splice donor/acceptor (+/-2bp) | 2 | 3 | 5 | |||
| Total | 8 | 10 | 69 | 30 | 1 | 118 |
Highest pathogenic variant AF is 0.00007806865
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001002755.1 | 8 | MANE Select | |
| Ensembl | ENSP00000387219.3 | 8 | MANE Select | |
| RefSeq | NP_001002756.1 | 4 | Standard | |
| RefSeq | NP_001361213.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- iron-sulfur cluster assembly
- protein maturation by iron-sulfur cluster transfer
Molecular Function
- iron ion binding
- protein binding
- 4 iron, 4 sulfur cluster binding
Cellular Component
- nucleus
- nucleoplasm
- mitochondrion
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000410022
- Coding exons
- 8
- Length
- 41879
- Individuals with no LoFs
- 125704
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 43
- Defined
- 125747
- p
- 0.000171
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.370 | 123 | 135 | 0.910 | 0.00000623 | 1653 |
| Missense (PolyPhen) | 40 | 45.843 | 0.87254 | 604 | ||
| Synonymous | 0.598 | 42 | 47.2 | 0.889 | 0.00000222 | 473 |
| Loss of Function | 0.940 | 10 | 13.8 | 0.727 | 5.80e-7 | 172 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00076 | 0.00074 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00012 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Iron-sulfur cluster scaffold protein which can assemble [4Fe-4S] clusters and deliver them to target proteins. {ECO:0000269|PubMed:12886008, ECO:0000269|PubMed:27818104, ECO:0000269|PubMed:28906594}.;
- Disease
- DISEASE: Multiple mitochondrial dysfunctions syndrome 1 (MMDS1) [MIM:605711]: A severe disorder of systemic energy metabolism, resulting in weakness, respiratory failure, lack of neurologic development, lactic acidosis, hyperglycinemia and early death. Some patients show failure to thrive, pulmonary hypertension, hypotonia and irritability. Biochemical features include severe combined deficiency of the 2-oxoacid dehydrogenases, defective lipoic acid synthesis and reduction in activity of mitochondrial respiratory chain complexes. {ECO:0000269|PubMed:21944046, ECO:0000269|PubMed:22077971, ECO:0000269|PubMed:25918518, ECO:0000269|PubMed:28161430, ECO:0000269|PubMed:28906594}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.144
Intolerance Scores
- LoFtool
- 0.621
- RVIS EVS
- 0.42
- RVIS percentile EVS
- 76.81
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.900
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |